ArticleArchives of osteoporosis2026
Polycystic ovary syndrome, insulin resistance, and bone health in Saudi women: a cross-sectional study.
Article in Archives of osteoporosis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Insulin resistance is common in Saudi women with PCOS and linked to hormonal imbalances. While bone health differences were not significant, trends suggest obesity and vitamin D may influence future risk. Early detection and management of insulin resistance could help reduce long-term health complications in affected women.
backgroundPolycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by hormonal, metabolic, and reproductive dysfunction. Insulin resistance (IR), a hallmark feature of PCOS, is associated with long-term health complications, including adverse effects on bone metabolism.
objectiveThis study aimed to explore the prevalence of IR in Saudi women with PCOS and investigate its associations with hormonal, metabolic, and bone health parameters.
methodsA cross-sectional study was conducted at the Center of Excellence for Osteoporosis Research, King Abdulaziz University, Jeddah, Saudi Arabia, between December 2018 and June 2019. A total of 144 participants were enrolled, comprising 72 women with PCOS and 72 age- and BMI-matched healthy controls. Anthropometric measurements, biochemical analysis, and bone mineral density (BMD) assessments were performed. IR was evaluated using fasting serum insulin, homeostasis model assessment (HOMA), and glucose-to-insulin ratio (GIR). Statistical analyses included group comparisons and correlation analyses to identify associations.
resultsIR was significantly higher in women with PCOS compared to controls across all diagnostic criteria (P < 0.01). PCOS women had higher luteinizing hormone (LH) levels and LH/FSH ratios (P < 0.001), particularly in insulin-resistant subgroups. No significant differences in BMD or T-scores were observed between groups; however, stratified analyses suggested trends toward higher T-scores in obese PCOS women. Vitamin D deficiency was similarly prevalent in both groups.
conclusionThis study highlights the substantial metabolic burden of IR in Saudi women with PCOS and its association on hormonal profiles. While no differences in bone health were observed, trends suggest that factors such as BMI and vitamin D status may be associated with skeletal outcomes at later stages. These findings underscore the importance of early IR identification and management to mitigate long-term health complications in PCOS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.